MedPath

Evaluation of oral erosion and prevention by Hangeshashinto in chemotherapy for esophageal cancer

Not Applicable
Conditions
Esophageal cancer
Registration Number
JPRN-UMIN000006201
Lead Sponsor
Chiba university
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
30
Inclusion Criteria

Not provided

Exclusion Criteria

1) no prior history of allergy in Hangeshashinto 2) patients to undergo other regimen of chemotherapy 3) no prior other Kanpo-drugs administered 4) severe organ failures 5) no prior history of opioids or steroidal treatments 6) active infection 7) concomitant active cancers 8) severe allergy for other drugs 9) patients who want to be pregnant or pregnant woman 10) severe constipation 11) pulmonary fibrosis 12) severe pshychological disorder 13) inappropriate cases for a clinical trials

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Rate of oral erosion
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath